Edwards Lifesciences Shares Soar 3.32% On Rival's Exit
Mover TrackerWednesday, May 28, 2025 6:47 pm ET
1min readEdwards Lifesciences (EW) shares surged 3.32% intraday, reaching their highest level since July 2024, marking a three-day winning streak with a cumulative gain of 2.50%.
The strategy of buying EW shares after they reached a recent high and holding for 1 week yielded moderate returns over the past 5 years. The annualized return was 8.14%, slightly underperforming the market benchmark. With a final value of $2,778.66 for a $1,000 investment, the strategy showed the impact of compounded returns over 5 years, highlighting the importance of holding periods to capture long-term gains..Edwards Lifesciences' stock experienced a notable rise due to a significant event involving its competitor, Boston Scientific. Boston Scientific announced that it would stop selling its rival heart-valve replacement systems, which led to a positive impact on Edwards Lifesciences' stock. This development highlighted the competitive advantage gained by Edwards Lifesciences as a result of Boston Scientific's exit from the market.
Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.
Comments
No comments yet